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Abstract
The tumor suppressors p53, p73, and p63 are known to function as transcription factors. They promote either growth arrest
or apoptosis, depending upon the DNA damage. A number of microRNAs (miRNAs) have been shown to function as
transcriptional targets of p53 and they appear to aid p53 in promoting growth arrest and apoptosis. However, the question
of p53/p63/p73 regulating the miRNA processing complex has not been addressed in depth so far. Comparative/
computational genomic analysis was performed using Target scan, Mami, and Diana software to identify miRNAs that
regulate the miRNA processing complex. Here, I present evidence for the first time that the tumor suppressors p53, p63, and
p73 function as both positive and negative regulators of the miRNA processing components. Curated p53-dependent
miRNA expression data was used to identify p53-miRs that target the components of the miRNA-processing complex. This
analysis suggests that most of the components (mRNAs’ 39UTR) of the miRNA processing complex are targeted by p53-
miRs. Remarkably, this data revealed the conserved nature of p53-miRs in targeting a number of components of the miRNA
processing complex. p53/p73/p63 appears to regulate the major components of the miRNA processing, such as Drosha-
DGCR8, Dicer-TRBP2, and Argonaute proteins. In particular, p53/p73/p63 appears to regulate the processing of miRNAs,
such as let-7, miR-200c, miR-143, miR-107, miR-16, miR-145, miR-134, miR-449a, miR-503, and miR-21. Interestingly, there
seems to be a phenotypic similarity between p63
2/2 and dicer
2/2 mice, suggesting that p63 and dicer could regulate each
other. In addition, p63, p73, and the DGCR8 proteins contain a conserved interaction domain. Further, promoters of a
number of components of the miRNA processing machinery, including dicer and P2P-R, contain p53-REs, suggesting that
they could be direct transcriptional targets of p63/p73/p53. Together, this study provides mechanistic insights into how
p53, p63, and p73 regulate the components of the miRNA processing; and how p53, TA-p63, and TA-p73 regulated miRNAs
inhibit tumorigenesis, EMT, metastasis, and cancer stem cell proliferation.
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Introduction
MicroRNAs (miRNAs/miRs) bind to 39UTR/CDS of mRNAs
and thereby they either promote their degradation or inhibit their
translation. MiRNAs are processed by Microprocessors in the
nucleus. Microprocessor consists of, namely, Drosha or RNASEN,
an RNAse III endonuclease, and DGCR8, a double stranded
RNA binding protein, The Drosha in complex with the DGCR8
processes (primary) pri-miRNA of several hundred base pairs in
length into stem loop structure containing 60-70-nt (precursor)
pre-miRNAs. Microprocessor also appears to consist of RNA
helicases, such as, p68 and p72. Both these proteins have been
shown to unwind double stranded stem loop containing pre-
miRNAs, and thereby they enhance their processing. The pre-
miRNAs are then transported out of the nucleus by RAN
GTPase/Exportin5(Expo5). The pre-miRNAs present in the
cytoplasm are processed by Dicer (an RNAse III endonuclease)
containing complex (miRNA-generating complex). This complex
consists of proteins, such as Dicer and TARBP2 (TAR binding
protein 2). The Dicer in conjunction with the TARBP2 cleaves 60-
70-nt pre-miRNAs into 21-22-nt mature miRNAs. This matura-
tion process is aided by Argonaute endonucleases (Agos), such as
EIFC1/Ago1 and EIFC2/Ago2, which bind to Dicer and
TARBP2. The complex containing Dicer, TARBP2, Agos, and
additional associated proteins is called as RNA-induced silencing
complex. The Ago1/2 enhances the processing efficiency and
cleavage of miRNAs. When there is a perfect match between
miRNAs and mRNA sequences, the Ago1/2 promotes the
degradation of mRNAs, while there is an imperfect match
between miRNAs and mRNAs sequences, it promotes transla-
tional repression. Of interest, Dicer not only plays a role in the
maturation of miRNAs, but also in siRNAs.
Considering miRNAs regulate one third of the genes present in
the human genome, it is important to understand how they are
regulated. MiRNAs, such as miR-34[a, b, c], miR-203, miR-29,
let 7, miR-15, and miR-16, and their processing components have
shown to be down regulated in multiple cancers. Ablation of
miRNA processing enzymes, such as Dicer1, Drosha, DGCR8,
and TARBP2, in cancer cells promotes more transformed
phenotype and invasive tumors, suggesting that miRNA process-
ing enzymes are required to control tumor- and metastasis-
initiating events. Importantly, ,50% of miRNAs are associated
with fragile sites of chromosomes, suggesting that they could play a
major in the control of cancer cell proliferation. In addition,
miRNA components, such as DGCR8, XPO5, TNRC6B, Ago1,
Ago 2, TARBP2, HSPCA, and SERBP1, have shown to be down
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10615regulated in lung cancer [1]. Interestingly, several miRNAs appear
to target the expression of the tumor suppressor p53 related
proteins, such as, p53, p63, and p73. p53 expression is inhibited by
miR-125b [2], while p63 is inhibited by miR-302, miR-21, and
miR-92 [3,4,5]. Based on these data, I have hypothesized that the
tumor suppressors, such as p53, p63, and p73, could regulate the
miRNA processing components.
Results and Discussion
p63 is a regulator of microRNA processing complex
The RNAse III ribonuclease, Dicer, has been shown to play a
role in stem cell renewal. Conditional knockout of Dicer in mouse
embryonic stem cells results in defective embryonic stem cell
proliferation/differentiation, indicating that Dicer plays a signif-
icant role in the control of stem cell renewal [6]. Inhibition of
Dicer expression has also been shown to down regulate the
expression of stem cell factors, such as Oct4 [Pou5f1], Sox-2 and
Nanog, indicating that its expression is required for the increased
expression of self-renewal factors [7]. Likewise, the Microprocessor
component DGCR8 appears to play a role in stem cell renewal
and skin development [6,7,8]. In addition, a defect in the DGCR8
gene has been shown to associate with a syndrome, which is
characterized by thymic hypoplasia, congenital heart defects, and
facial abnormality [9]. Interestingly, a number of reports strongly
suggest that p63 plays a major role in stem cell maintenance, skin
development, thymic proliferation, and cardiac morphogenesis
[8,10,11,12,13,14,15]. In addition, both TA-p63 and Dicer have
been shown to play a critical role in protecting the germ line
integrity of oocytes [16,17], suggesting a phenotypic match
between Dicer, DGCR8, and the p63 null mice.
It has previously been shown that WW domain-containing
proteins interact with the PY domain-containing proteins.
Remarkably, DGCR8 contains a WW domain [18], while p63
contains a PY domain [19], indicating a possibility of an
interaction between the WW domain of DGCR8 and the PY
domain of p63 [Figure 1]. Interestingly, it has been postulated that
Drosha interacts with the WW-domain of DGCR8 through its PY
domain [18]. Together, these data suggest that: a) p63 and
DGCR8 proteins contain a conserved interaction domain; b) p63
Figure 1. p63 is a regulator of microRNA-processing pathway.
doi:10.1371/journal.pone.0010615.g001
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p63, by interacting with DGCR8, it could influence its ability to
process pre-miRNAs.
Further, it has been shown that p63 null mice fail to develop
hair follicles. However, how p63 regulates hair follicle develop-
ment is not known yet. It has recently been shown that epidermal
specific knockout of Dicer results in stunted development of hair
follicles and hypo proliferation, reassuring a phenotypic match
between the p63 and the Dicer null mice [20]. In connection with
these findings, it has recently been shown that in the absence of
Dicer or miR-203, DNp63 expression is not switched off in the
suprabasal cells of the epidermis [8], indicating that Dicer-
mediated miRNA processing is required for the down regulation
of DNp63. Thus, it is plausible that p63 and Dicer could regulate
each other to control the hair follicle and epidermal development.
Next, I have investigated whether p63 could function as a
regulator of the Microprocessor component Drosha. p63/DNp63
has been shown to bind to Smad5 [21], suggesting a possibility
that it could regulate the signaling cascade mediated by Smad5.
Interestingly, it has recently been shown that Smad5/1 interacts
with the Drosha/p68, and thereby promotes the processing of pri-
miR-21 [22]. These findings suggest that DNp63, by binding to
Smad5, it could promote the association between Drosha and pri-
miRNAs. This will result in increased processing efficiency of
growth promoting pre-miRNAs, including pri-miRNA-21. Fur-
ther, Foxo3a has recently been shown to suppress the expression of
miR-21. Another study showed that p53 suppresses the expression
of Foxo3a through its transcriptional target HDM2, suggesting
that p53/TA-p73 could induce the expression of miR-21.
Interestingly, miR-21 has been shown to suppress the expression
of TA-p63/p53 [5], indicating a feedback loop between DNp63/
p53/TA-p63/p73 and miR-21[Figure 1]. Thus, DNp63, by
increasing the expression of mature miRNA-21, it could suppress
the expression of tumor suppressor genes, including TA-p63 and
p53 [Figure 1].
Further, Dicer expression appears to be down regulated in
metastatic prone tumors [23], indicating that it could function as a
tumor/metastasis suppressor. Interestingly, p63/p73 heterozygous
mice are prone to metastasis, indicating that the tumor suppressor
TA-p63/p73 could function as a positive regulator of the
suppressor of metastasis Dicer. These reports prompted me to
analyze the Dicer promoter sequence for p63 responsive elements.
Evidently, I have found two perfect p63/p53-REs half sites and
eight nearly perfect p63/p53-REs in the Dicer promoter [Table 1],
indicating that it could be a direct transcriptional target of p63/
p53/p73. In support of this data, a study showed that Dicer is
differentially expressed in response to TA-p63 expression,
indicating that it could indeed be its transcriptional target
Table 1. The promoters of the key components of the miRNA processing machinery contain p53/p63-REs.
miRNA processing components
Position in the promoter
sequences (human)
p53/p63-REs present in the promoters of the
microRNA-processing components
Drosha or DNASEN 22695 to 22672
22025 to 22000
21996 to 21970
21832 to 21797
21868 to 21841
21282 to 21253
21000 to 2975
(ctacaggctc)atc(caccatgccc)
(ccccttgaactcaacaggtcatgtgg)
(ccccttgaac)tcaaca(ggtcatgtgg)
(gatcatggct)cactgc(agccttgga)(ctcctgggtt)
(gggcttgtcagttgcccagcctggaaagcagt)
(atccatgggc)ctcctttgt(tgacttggaa)
(tagctgggta)cggtg(atgcgtgcct)
DGCR8 22845 to 22821
22797 to 22777
22590 to 22570
21346 to21320
2500 to 2475
2225 to 2203
247 to 26
(acgcatgtg)catg(catgcgtgttc)
(gtgcgtgtgt)(ctgcatgtgt)
(tatctggacc)(agtcatggct)
(gggcttgtaa)aactct(ggtcttgtaa)
(ggccttgaat)ttccc(ctacgaggtat)
(tagcttggga)agcttc(cgccgagggt)
(gagcatgagc)gccaggg(gctctggtgt)ctgaa(cagcgtgttt)
Dicer* 23127 to 23107
23362 to 23342
22071 to 22051
21999 to 21972
21961 to 21933
2740 to 2728
2386 to 2362
2347 to 2319
2256 to 2246
2211 to 2202
(aggcatggtg)(atgcgtgctg)
(aggcgtggtg)(gtgcacgcct)gta(gtcccagtta)
(acacttggat)t(gcacttgagg)
(acccgtggac)tatctga(aatcaggaga)
(aaacttgccc)aaggggta(gcccaagagg)
(aagcaatagc)ct(tagcatgttc)
(tgcctgggat)tcca(acccgtgaag)
(ctgcaggatg)cctgcaag(cttcgtgacc)
(aaccatgtcc)
(aaacttgctt)
TARBP2 23761 to 23734
23334 to 23353
23314 to 23294
22952 to 22932
22787 to 22763
22632 to 22614
22437 to 22403
22155 to 22135
2998 to 2970
2598 to 2565
233 to 23
(tcacttggtc)ttgttac(gggcatgatt)
(atgcatgagt)(ggctggcgt)
(tcactggaag)(aagcatggca)
(tagctggtgt)(ctccatgttg)
(ggacaggaag)(gctcaggggg)(cacttgagt)
(tggcttgaga)cg(actctgggtg)
(ggccttggtt)ac(cagcaagtct)ca(actcttgttt)
(gggcatgcag)(gaacaggtgc)
(gatcttgcca)gctctcct(tcccttgatt)
(actcatggaa)ag(gaacaagacc)accaaggtg)
cgccatgaagcttct(cgtg)(cgtg)(cttg)acc
p53/p63/p73 may regulate the microRNA processing components through its responsive elements present in their promoters.
* Microarray data suggest that this gene is induced in response to TA-p63/DN-p63 expression (Promoter sequence of this gene serves as a positive control).
doi:10.1371/journal.pone.0010615.t001
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promoters of a number of other miRNA-processing components
[Table 1] [Table S1], suggesting that they could be direct
transcriptional targets of p53/p73/p63.
The RNA binding protein, P2P-R, has been shown to bind to
Dicer/TARBP2/Ago2, and thereby enhances the processing of
mature miRNAs [24,25] [Figure 1]. Inhibition of P2P-R appears
to inhibit the production of mature miRNAs, indicating that it
could be part of the RNA-induced silencing complex. It also
appears to enhance the siRNA-induced RNA interference.
Bioinformatics analysis of P2P-R promoter suggests that it contains
five nearly perfect p63/p53- REs[Table S1], indicating that it
could be a transcriptional target of p63. Evidently, a study showed
that P2P-R is differentially expressed [3.2 fold] in response to DN-
p63 expression, indicating that it could indeed be its transcrip-
tional target. Interestingly, P2P-R has been shown to promote the
binding of MDM2 to the tumor suppressor p53, and thereby
interferes with its ability to transactivate its target genes [26]
(discussed in detail later). Therefore, these data suggest that DN-
p63, by increasing the expression of P2P-R, it could increase the
processing of Pre-miRNA into mature miRNAs (eg. Oncogenic
miR-21) [Figure 1]. Taken together, p63, by increasing the
expression of the miRNA processing components [Table 1], it
could enhance the processing of miRNAs and siRNAs.
p73 is a regulator of microRNA processing complex
The tumor suppressor p73 gene is located on chromosome
1p36.3, while Argonaut genes, Ago1, Ago3, and Ago4, are located
on chromosome 1p34-35. Interestingly, 1p34-35 region is shown
to be lost in Wilms tumors [27], suggesting that the Agos may
function as tumor suppressor genes. Further, there seems to be a
phenotypic similarity between Dicer and p73 null mice. Both p73
null and Dicer-hypomorphic mice are: a) hyper susceptible to
infections; and b) infertile [28,29]. In addition, lung specific Dicer
knock out mouse model suggests that it is essential for lung
morphogenesis [30], while TA-p73 specific knockout mice suggests
that it is essential to inhibit the development of lung carcinoma.
It has recently been shown that the ubiquitin ligase TRIM32
binds to Ago-1[31]. The C-terminal NHL domain of TRIM-32
forms complex with Ago1, and thereby promotes the efficiency of
processing of a number of miRNAs [Figure 2], including let-7,
miR-134, miR-130, miR-214, 449, 379, 181, and miR-503 [31].
To find out whether the tumor suppressor TA-p73 could increase
Ago-1 expression through TRIM32, I have analyzed both human
and mouse TRIM32 promoter sequences for putative p53/p63-
REs. Remarkably, I have found five p63/p53-REs both in the
human and mouse TRIM32 promoters, indicating that it could be
a transcriptional target of TA-p73/p63; and p53 [32]. Evidently, a
recent microarray study suggests that TRIM32 expression is
Figure 2. p73 is a regulator of microRNA-processing complex.
doi:10.1371/journal.pone.0010615.g002
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data suggest that the TA-p73, by increasing the expression of
TRIM32, it could increase the Ago1/2 activity [Figure 2].
Interestingly, a domain present near the carboxyl terminus of
p73 is homologous to enodonuclease III. Thus, it would be
interesting to test whether this domain participates in Ago-19s
ability to enhance the miRNA processing. In addition, both Ago-1
and -2 promoters appear to contain p53/p63-REs [Table 1],
suggesting that they could also be direct transcriptional targets of
p53/TA-p73/p63. Thus, p73, by increasing the expression of
Ago-1/2, it could increase the processing of miRNAs, such as let-7
(HMGA2; lin-28; EGFR; Kras; c-myc; Bcl-xL), miR-134 (Nanog;
LRH1; Oct-4; Collagenase-3; Stromelysin), miR-130b (ERK2;
Fosl1; TGFbR1; ERa; Tcf-4; Collagenase-3; Ago4; Dicer; p63),
miR-214 (EZH2; CTNNB1), miR-449a (CDK6; SirT1; HDAC1;
E2F-1), miR-503 (CCND1; Fosl1), miR-181d (ERK2; TGFbR1;
Tcl-1; ERa; AID; Bcl-2) and miR-379 (lin-28) [Figure 2] [31,32].
Increased expression of these miRNAs will activate tumor
suppressor mechanisms and thereby suppress Epithelial to
Mesenchymal transition (EMT), metastasis, and cancer stem cell
(CSC) proliferation [Figure 2] [32].
Further, like p63, p73 contains the PY domain [34], suggesting
that it could interact with the WW domain of DGCR8, and
thereby influence its ability to process miRNAs [Figure 2].
It has recently been shown that let-7 suppresses the expression
of Dicer, which, in turn, suppresses the expression of let-7,
indicating a double negative feedback loop [35,36]. This data
suggests that TA-p73, by increasing the expression of the tumor
suppressor let-7, it could indirectly regulate the expression of
Dicer. It may even directly regulate the expression of dicer
through its responsive elements present in the dicer promoter in a
cell context dependent manner [Table 1]. In addition, both let-7
and lin-28 (an RNA binding protein) have been shown to inhibit
each other’s expression [37,38]. This finding suggests that TA-
p73/p63/p53, by suppressing the expression of lin-28 through let-
7, it could regulate the miRNA-processing efficiency.
It has recently been shown that TA-p73 null mice are prone to
lung cancer, indicating that it functions as a tumor suppressor gene
[29,39,40]. Dicer gene is shown to be located on chromosome
14q32.13, while p73 gene is located on chromosome 1p36.3.
Interestingly, these chromosomal loci are frequently lost in a
number of cancers, including lung cancer. Evidently, Dicer
expression appears to be lost both in advanced invasive lung
cancer [41] and in non-small cell lung cancer [42]. In support of
these findings, a study has recently found heterozygous germline
mutations in the Dicer gene in a pediatric lung carcinoma [43],
indicating that decreased expression of Dicer may serve as an
initiating event for the development of lung carcinoma and
metastasis. It has been shown that EMT promotes metastasis, self-
renewal, and migration of cancer stem cells. Interestingly, Dicer
expression appears to be lost in epithelial component, but retained
in mesenchyme, suggesting a disruption of homeostatic mecha-
nisms [43]. In support of this finding, a recent study suggests a
lower expression of Dicer is associated with the mesenchymal
phenotype [44]. Interestingly, this has matched in patients with the
metastatic relapse of breast cancer [44]. These data suggest that
Dicer could function as a metastasis suppressor gene. Intriguingly,
p73/p63 heterozygous mice are more prone to sarcoma (mainly
originates from mesenchymal cells) and metastasis when compared
to p53 heterozygous mice, indicating that p73/p63 could function
as a suppressor of sarcoma and metastasis. Evidently, TA-p73/p63
appears to increase E-cadherin expression (a negative regulator of
EMT), by suppressing ZEB1/2 through its target miRs, such as
miR-192, miR-215, miR-145, miR-203, miR-200b, miR-200c,
miR-183, miR-92a/b, miR-132, and miR-30a-e [45]. Therefore,
these data suggest that p73/p63, by increasing the expression of
Dicer in epithelial cells, it could prevent the development of
sarcoma and metastasis. Together, these data support the notion
that TA-p73/p63 could function as a metastasis suppressor.
p53 is a regulator of microRNA processing complex
It has been shown that Dicer is over expressed in prostate
cancer and in the initial stages of adenocarinoma [1,41],
suggesting that it is deregulated in a tissue/stage specific manner
in cancer. As discussed, Dicer appears to be required for the
increased expression of self-renewal factors, indicating a pro-
proliferative role for dicer [8]. However, Dicer also appears to play
a tumor suppressor role. This is evident from the following studies:
a) Ablation of Dicer in a k-ras induced mouse model of lung
cancer enhances tumorigenesis. b) Mutation in TARBP2 protein
destabilizes Dicer protein and promotes tumor growth. Converse-
ly, reintroduction of a wild-type TARBP2 increases the Dicer
stability, and thereby inhibits tumor growth [46]. c) Hepatocytes
specific knockout of Dicer in mice promotes hepatocellular
carcinoma after one year [47]. In addition, conditional knockout
of Dicer both in liver and lung promotes apoptosis [30,47],
suggesting that increased expression of pro-apoptotic factors, such
as tumor suppressor genes, may cause apoptosis. Together, the
role of Dicer in the control of cell proliferation remains nebulous.
Further, targeted deletion of Dicer/DGCR8/HDM4(the negative
regulator of p53) in heart results in dilated cardiomyopathy
[48,49,50]. This data suggests that constitutive expression of p53–in
the absence of its negative regulator MDM4–in cardiomyocytes may
promote apoptosis by suppressing the expression of Dicer. Perhaps
this also explains why mice lacking Dicer and DGCR8 are
developing dilated cardiomyopathy. Of interest, a mutation in
DGCR8 gene is characterized by congenital heart defects [9].
These reports prompted me to surmise that Dicer could be a
transcriptional target of p53/p63/p73. As discussed, Dicer
promoter contains several p53-REs, indicating that it could be a
transcriptional target of p53/p63/p73. However, analysis of its
p53-REs sequence [Table 1] suggests that—‘‘CGTG’’: p63
specific; CATG: p53 specific— it could be a preferential
transcriptional target of p63/p73 rather than p53.
Further, p53 appears to regulate the expression of Dicer
through its transcriptional target miRs, such as miR-192, 215,
miR29a/b/c, miR-148, miR-15/16a, miR-206, and miR-103
[Table 2], suggesting that p53/p63/p73 could regulate the
expression of dicer both at the transcriptional and the post-
transcriptional level. Interestingly, these p53-miRs have been
shown to promote growth arrest and apoptosis. Considering the
tumor suppressor p53 is a negative regulator of stem cell
proliferation and reprogramming factors (eg. Nanog, Oct-4,
Klf4, Sox-2, lin-28, and c-Myc, Boominathan, published else-
where) [32], it is unsurprising that it could function as a negative
regulator of Dicer.
It has recently been shown that Dicer is required to maintain
hypermethylation in cancer cells[51], indicating that aberrant
expression of Dicer could deregulate the expression of tumor
suppressor genes in cancer cells. Evidently, knock down of Dicer
results in up regulation of the tumor suppressors p53 and p19ARF,
which in turn promote senescence [52]. Deletion of Dicer has also
been shown to result in up regulation of the tumor suppressor
p130, which in turn represses the expression of DNMT3a and
DNMT3b [53]. This appears to occur through down regulation of
miR-290, which functions as a suppressor of the expression of
p130. Together, these data suggest the following: a. p53 and Dicer
may share a reciprocal relationship. b. p53 may fine-tune Dicer
p53/p63/p73 Regulates miRNAs
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expression of Dicer may either promote or inhibit tumorigenesis
and metastasis in a cell context dependent manner. d. p539s ability
to regulate Dicer expression could be part of its intrinsic tumor
suppressor mechanism.
Under physiological conditions, p53 will be in its inactive form,
thus its transcriptional target miRs will be poorly expressed. This
will result in stabilization of Dicer, which in turn, will promote the
processing of growth promoting miRNAs. While in response to
stress, p53 will be active, thus its transcriptional target miRs will
repress Dicer function. This notion is supported by data showing
that down regulation of Dicer expression elicits DNA damage
response [54]. This results in activation of the tumor suppressors
p53 and ARF. Of importance, it has recently been shown that the
ability of some of the miRNAs to cause translational repression of
their targets is compromised in response to stress [55]. However,
this does not explain how stress related miRNAs, such as miR-34,
miR-192, and miR215, are produced in a p53-dependent manner
in response to DNA damage. If these miRNAs are processed
independent of Dicer function or regulated in a context dependent
manner, then one can explain this conundrum. Therefore, it
would be fascinating to test how TA/DN-p63/p73/p53 and Dicer
regulate each other both in response to DNA damage and under
physiological conditions.
MiRNAs have been shown to inhibit the expression of the tumor
suppressor p53 (miR-125a/b) and p63 (miR-92, miR-21, 302 and
miR-203) [Table 3], indicating that Dicer function may be required
to generate mature miRNAs. Besides, miR-150 and miR-22 are
predicted to inhibit the expression of p53 [Table 3]. However, it is
important to keep it in mind that miR-150 is expressed only in
mature lymphocytes. Interestingly, p53 has been shown to suppress
the expression of miR-125b and miR-22 [56], indicating that it could
repress its negative regulators to increase its expression.
Let-7 miRNA is highly conserved from lower organisms to
humans. A number of studies suggest that it function as a tumor
suppressor gene. Estradiol, an inducer of p53 expression, has been
shown to increase the expression of eight members of the let-7
family. Evidently, let-7a (2.1 fold), let-7c (2.7 fold), and let-7e (2.1
fold) are induced in response to p53 expression [56]. Remarkably,
the let-7 family promoters contain p53-REs [40], indicating that
they could be indeed be direct transcriptional targets of p53/p73/
p63. Surprisingly, let-7c (Context score percentile: 87) and let-7a
(Context score percentile: 87) are predicted to target the
expression of p53 (Target scan) [Table 3]. This data suggests a)
a feedback loop between p53 and let-7; and b) the ability of let-7c
and -7a to inhibit p53 expression may be relieved in response to
DNA damage [57]. Evidently, let-7 has recently been shown to
increase the expression of its target mRNAs under stressful
conditions [57]. Thus, this data suggests that let-7 may increase
the translation of p53 mRNA under genotoxic conditions.
The stem cell renewal factor, lin-28, has been shown to suppress
theprocessing of pre-let-7 atthe Microprocessor step [37].It interacts
with let-7 precursor loop, and thereby inhibits its processing in
embryonic stem cells [58]. It has also been shown to mediate
Table 2. p53/p63/p73-microRNAs that target essential components of the miRNA processing machinery.
miRNA processing
components Target miRNAs
Target scan’s Context percentile/Mami
score(in decimals)/miTG score (in italics)
Transcriptional targets of p53/p63/p73/target
miRNA- processing components/comments
DROSHA or DNASEN miR-27a/b
miR-128
83
40
p53
p53
DGCR8 miR-9
miR-27a
miR-31
67
8.25
67
p53
p53
p73/p63/p53
Dicer miR-103
miR-107
miR-16*
miR-15*
miR-206
miR-29a/b/c
miR-192*
miR-215*
let-7 a to g
miR-124
miR-200a
miR-130a/b
miR-203
miR-31
95
33.45
52
42
89
80
86
86
31.95 to 8.6
14.2
7.8
82/75
72
73
p53
p53
p53
p53/p73
p53
p53; increases p53 expression
p53
p53
p73/p63/p53
p53
p53
p73
p53/p73/p63
p73/p63/p53
TARBP2 Let-7a to g
miR-15a/b*
miR-16*
miR-195
miR-103
miR-107
miR-183*
miR-34b*
66–72
86
89
89
0.09432
0.09432
0.09432
0.09432
p73/p63/p53
p53/p73/p63
p53/p73/p63
p53/p73/p63
p53
p53
p53/p73
p53/p73
Exportin 5 miR-34a*
miR-143
miR-124
miR-29a/b/c
92
62
12.72
10.25 to 10.13
p53/p73
p53
p53
p53
p53/p63/p73 proteins increase the expression of miRNAs to regulate the components of the miRNA-processing complex [56, 69, 70, Boominathan, unpublished].
* Experimentally verified transcriptional targets of p53.
doi:10.1371/journal.pone.0010615.t002
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let-7 fails to be processed by the Dicer complex and therefore
undergoes degradation in the cytoplasm. However, the enzyme that
uridylates let-7 precursor remains obscure. Remarkably, Heo et al.,
[60] have recently showed that lin-28 recognizes a sequence motif—
GGAG—present in let-7, and recruits TUTase-4 [TUT4, uridyl
transferase]. The TUTase4 uridylates let-7 precursor, and thereby
inhibits its processing [Figure 3]. Further, Let-7 has recently been
shown to reduce the expression of stem cell reprogramming factors,
such as Klf-4, Oct-4, Sox-2, and c-Myc [59,61]. Interestingly,
knockdown of lin-28 and TUTase4 results in down regulation of stem
cell markers, indicating that both lin-28 and TURase4 are required
for the stem cell maintenance [60]. As discussed, p53/TA-p73/p63,
by increasing the expression of let-7, it could suppress the expression
of the stem cell reprogramming factor lin-28 [37,38,40]. Together,
p53/TA-p73, by increasing the processing of the tumor supp-
ressor let-7, it could inhibit the stem cell proliferation/renewal/
maintenance.
Further, p53-miRs, such as miR-96 and miR-132 [56], are
predicted to target the expression of TUTase4 (Target scan)
[Table 2]. This data suggests that p53/TA-p73/p63, by
suppressing the TUTase4 expression through its target miRs, it
could increase the processing of the tumor suppressor let-7. This
data further strengthens the notion that p53/TA-p73/p63, by
increasing let-7 expression, it could reduce stem cell proliferation/
renewal/maintenance [Figure 3].
Lin-28 may also mediate uridylation of other miRNAs, such as
miR-143, 200c, and 107, as these miRNAs share the sequence motif
Table 3. p53, p63, and p73 are negatively regulated by miRNAs.
p53 related proteins Targeting miRNA (verified) Putative miRNAs that target p53 related proteins (human and mouse)
p53 miR-125a/b miR-150; let7-i; let-7f; miR-98; let-7c,b, a, g, d; miR-22; miR-612
p63 mirR-302 and miR-21 miR-92; miR-101; miR-519C-3p; miR-519a; miR-519b-3p; miR-301a/b; miR-454; miR-130a/b;
miR-367; miR-363; miR-372; miR-373; miR-377; miR-543; miR-590-3p; miR-340; miR-137; miR-
543; miR-590-3p; miR-32; miR-495; miR-181c; miR-181a; miR19a/b
DN-p63 miR-203 and miR-92 -
p73 - miR-125a/b; miR-205; miR-485-5p; miR-193a/193a-5p; miR-612
miRNAs targeting p53, p63, and p73 were analyzed using the Target scan, Diana and Mami softwares.
doi:10.1371/journal.pone.0010615.t003
Figure 3. p53, TA-p73/p63, and DNp63 regulate the processing of the tumor suppressor miRNAs, let-7, miR-200, miR-143, and miR-107.
doi:10.1371/journal.pone.0010615.g003
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processing [58,56] [Figure 3]. Remarkably, these miRNAs have been
predicted to function as transcriptional targets of p53/TA-p73/p63
[45, 56, 69, Boominathan, unpublished]. A) miR-143 has been
shown to inhibit the expression of DNMT-3a [62]. It also appears
target the expression of k-ras, AID, and ERK2. Inhibition of
DNMT3a may result in reactivation of tumor suppressor genes in
cancer cells, while inhibition of ERK2 may result in down regulation
of the EMT activator and the metastasis promoter ZEB1/Fosl1
expression. B) The tumor suppressor miRNA, miR-200c has also
been shown to inhibit the expression of ZEB1 [45]. Interestingly,
ectopic expression of miR-200c has been shown to inhibit lung
carcinoma cell lines’ ability to undergo EMT, invade, and
metastasize. Considering ZEB1 is a suppressor of E-cadherin, TA-
p73 and p21 expression, increased expression of miR-200c (an
inducer of epithelial phenotype) will result in increased expression of
the tumor suppressor E-cadherin/TA-p73/p21 and in turn, this will
result in inhibition of proliferation, EMT, invasion, metastasis and
CSCs proliferation [45,63,64,65,66,67]. C) miR-107 has recently
been shown to promote cell cycle arrest [68]. It also suppresses HIF-
1b and VEGF expression, and thereby inhibits tumor angiogenesis.
Together, these data suggest that p53/TA-p73/p63, by negatively
regulating the expression of lin-28/TUT4ase through its target miRs,
it could increase the processing of the tumor suppressor-miRNAs, let-
7, miR-200c, miR-143, and miR-107 [Figure 3]. Increased
expression of these tumor suppressor miRNAs will result in inhibition
of tumorigenesis, EMT, invasion, and metastasis.
Further, p53-miRs, such as miR-181c, 30b and 92 [Table S2],
are predicted to target lin-28B [56,69,70], indicating that p53, by
suppressing the expression of lin-28B, it could increase the
processing of the tumor suppressor miRNA, let-7. Interestingly,
increased expression of let-7 has been shown to increase the
expression of Ago-2 [71]. This data suggests that p53/TA-p73/
p63 could increase the expression of Ago-2 through its target gene
let-7, and thereby it could increase the processing efficiency of
miRNAs [Figure 3].
miRNA-145, a transcriptional target of p53/TA-p73/p63, has
recently been shown to suppress c-Myc (a transcriptional activator
of lin-28), metastasis promoting factors (Fascin, mucin1), and stem
cell reprogramming factors (Oct-4, Klf-4, Sox-2) [72,73]. This
data suggests that p53/TA-p73/p63, by negatively regulating c-
Myc/lin-28 through its transcriptional target miR-145, it could
increase the expression of let-7 [73]. HMGA2 has been shown to
suppress the expression of INK4a/ARF expression [74]. Interest-
ingly, let-7 has recently been shown to suppress the expression of
HMGA2, suggesting that p53/TA-p73/p63, by increasing the
expression of let-7, it could increase the expression of INK4a/ARF
(TAp73/p63-let-7-HMGA2-INK4a/ARF) [Figure 3]. This notion
is in concordance with the tumor suppressor—E2F-1-TA-p73/
p63-JunB-INK4a/ARF– pathway that I have proposed previously
[39,40]. HMGA2 has also been shown to function as an activator
of Snail1 and Slug (Snail2) expression (inhibitors of E-cadherin/
miR-200 expression), suggesting that p53/TA-p73/p63, by
suppressing the expression of both Snail and Slug, it could induce
the expression of E–cadherin and miR-200. Together, p53/TA-
p73/p63, by increasing the expression of miR-145, let-7, and miR-
200, it could decrease the expression of metastasis promoting
factors, and stem cell factors.
Further, a microarray study suggests that DN-p63 expression
increases the expression of c-Myc [75]. This data suggests that
DN-p63, by increasing the expression of c-Myc, it could increase
the expression of lin-28. Increased expression of lin-28 will
suppress the processing of let-7 pre-miRNA. Interestingly, DN-p63
expression has shown to be suppressed by miR-203, a transcrip-
tional target of p53/TA-p73/p63 [76] [Figure 3]. This data
suggests a double negative feedback regulation between DN-p63
and p53/TA-p73/p63 [76]. Further, mLin41/TRIM71, an E3
ubiquitin ligase, has recently been shown to mediate Ago-2
ubiquitylation [77], and thereby reduces the silencing efficiency of
miRNAs. Interestingly, let-7, by suppressing mLin41 expression, it
could enhance the Ago-2-dependent silencing efficiency of
miRNAs. Together, these data suggest that both p53/TA-p63/
p73 and DN-p63 could regulate the processing of tumor
suppressor let-7 through their transcriptional targets in a cell
context dependent manner [Figure 3].
miR-183 has recently shown to be induced in response to p53
expression [56]. Evidently, bioinformatics analysis of its promoter
revealed a number of p53-REs, suggesting that it could be a
transcriptional target of p53 [Boominathan, unpublished]. It has
recently been shown that miR-183 binds to the coding region of b-
transducin repeat-containing protein 1 [bTrCP1] mRNA, a
substrate recognition protein of the SCF E3 ubiquitin ligase
complex, and thereby destabilizes it by recruiting the Ago-2
containing RNA-induced silencing complex [78,56] [Figure 4].
Interestingly, both Ago-2 and miR-183 bind to the over lapping
region of bTrCP1. Furthermore, IGF2BP1 has been shown to
bind to the coding region of bTrCP1, c-myc, and MDR-1
mRNAs, and thereby protects them from degradation [78].
Remarkably, let-7 has recently been shown to suppress the
expression of IGF2BP1, suggesting that it could destabilize
bTrCP1, c-myc, and MDR-1 mRNAs. miR-183 also appears
target the expression of ZEB1 [45], TCF-4, and NFKB1, an
activator of lin-28, IL-6 and Snail1 (inducers of EMT & metastasis)
expression(Target scan). Together, these data suggest that p53, by
inducing miR-183 and let-7, it could promote the destabilization/
degradation of oncogenic mRNAs (bTrCP1, c-myc, MDR-1,
IGF2BP1, ZEB1, TCF-4, NFKB1) and thereby suppress the
expression of metastatic factors [79] [Figure 4].
p68 is an ATP-dependent RNA helicase that helps in unwinding
stem loop containing pri-miRNAs. It appears to be part of the
Drosha complex. It has been shown to unwind the stem loop
structures of the tumor suppressor miRNA, let-7 [80]. It has also
been shown to function as a co-activator of p53 in response to DNA
damage [81]. Interestingly, p68 promoter contains p53-REs [Table
S1], indicating that p53 may increase its expression to increase the
processing efficiency of the Drosha complex [Figure 4].
As discussed before, P2P-R has been shown to interact with
integral components of the RNA-induced silencing complex, such
as Dicer, TARBP2 and hAgo-2. It also interacts with p53 and
HDM2, indicating that p53 could either be part of the RNA-
induced silencing complex or it could regulate the formation of the
RNA-induced silencing complex. Interestingly, DN-p63, which
has been shown to antagonize p53/TA-p63/p73 functions,
appears to increase the expression of P2P-R [Figure 4]. Increased
expression of P2P-R has been shown to augment HDM29s ability
to ubiquitinate p53, and thereby promotes it for degradation [26].
This data suggests that DN-p63, by increasing the expression of
P2P-R, it could decrease the p53 protein levels. DN-p63-mediated
down regulation of p53 and its target miRNAs may result in
increased expression of Dicer [Figure 4]. It is possible that this
regulatory mechanism is functional only under proliferation
promoting conditions. Remarkably, p53-miRs, such as miR-15,
16, and 29a/b/c, are predicted to inhibit the expression of P2P-R
[Table S2], suggesting that there could be a feedback loop
between p53/DN-p63 and P2P-R [Figure 4]. Interestingly, miR-
15/16/29 promoter contains p53/p63-REs, suggesting it could be
a direct transcriptional target of p53/TA-p73/p63 (Boominathan,
unpublished).
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RNA/DNA binding proteins. Depletion of these proteins appears to
causegrowth inhibition [82]. Interestingly, it has recently been shown
that both NF90 and NF45 function as negative regulators of the
miRNA processing [83]. They do not appear to bind to any of the
known miRNA processing components, but they interact with pri-
miRNAs of let-7 and miR-21. By interacting with let-7/miR-21 pri-
miRNAs, they inhibit the processing of let-7/miR-21 pri-miRNAs
into pre- miRNAs. Interestingly, both ILF-3 and ILF-2 promoters
contain p53-REs [Table 1], suggesting that they could be direct
transcriptional targets of p53 or p53 related proteins. Further, ILF-3
and ILF-2 are targeted by miR-181b/c and miR-25, respectively
[Table S2]. Together, these data suggest that both p53 and p53-
miRs, by controlling the expression of both ILF-3 and ILF-2, they
could regulate the processing of let-7/miR-21 pri-miRNAs.
Estrogen receptor-a (ER-a) has been shown to attenuate the
Drosha-mediated cleavage of pre-miR-145/16/143 [84]. Inter-
estingly, p53-miR-145 has recently been shown to inhibit the
expression of ER-a [85], suggesting that p53/p73/p63 could
function as a positive regulator of the processing of the tumor
suppressor miRNA-145/16/143. As discussed, p73 may inhibit
the expression of ER-a through its ability to increase the
processing of miR-130b/181d. Further, hnRNP A1, an RNA
binding protein, has been shown to interact with conserved loops
of pre-miR-18a and thereby promotes its cleavage mediated by the
Drosha complex [86]. Interestingly, p53 appears to inhibit the
expression of hnRNP A1 through its target miRNA-15/16,
suggesting that p53/p73/p63 could function as a negative
regulator of the processing of the oncogenic miRNA-18a.
Together, these data suggest that p53, p73, and p63, by
controlling the expression of auxiliary factors necessary for the
processing of specific miRNAs, they could function either as a
positive or as a negative regulator of the miRNA processing in a
cell context dependent manner.
p53/p63/p73-miRNAs’ ability to target the components
of the miRNA processing complex are conserved
Among the p53-miRs that target the components of the miRNA
processing complexes, miR-15/16/195, miR-103, miR-107, let-7,
miR-124, miR-181, miR-148a/b, miR-30a/c, miR-27, miR-17,
and miR-20 appear to target more than five components of the
miRNA-processing pathway [Table 4, Table S3], suggesting the
conserved nature of p53-miRs. In response to p53 activation, miR-
17, miR-20, miR-27a, miR-15a, miR-15b, and miR-16 are
induced 4, 7.7, 5.2, 5.2, 8.2, and 2.9 folds respectively, compared
to controls [56].
As discussed, miRNAs are processed by the RNAse III
containing complexes, such as Drosha-DGCR8 (in the nucleus);
and Dicer-TARBP2 (in the cytoplasm). Interestingly, both Drosha
and DGCR8 appear to be targeted by p53-miR, miR-27, while
both Dicer and TARBP2 appear to be targeted by p53-miRs, such
as let-7, miR-103/107, and miR-15/16/195, suggesting a co-
ordinated regulation of miRNA processing mediated by the p53-
miRs. The data presented in Table 4/Table S3 suggests the
conserved nature of p53/p73/p63-miRs in targeting a number of
components of the miRNA processing complex.
The miRNA processing components’ function appears to be
profoundly influenced by the p53, p63, and p73. Table 1 [Table
Figure 4. p53 is a regulator of microRNA-processing complex.
doi:10.1371/journal.pone.0010615.g004
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could be direct transcriptional targets of p53/p63/p73. Table 2
[Table S2] shows that the p53/p63/p73-dependent miRNAs
could regulate the expression of the miRNA processing compo-
nents. These data strongly suggest that p53, p63, and p73 may co-
operate with each other in regulating the miRNA processing
components. In addition, there could be positive and negative
feedback loops between p53/TA-p63/p73/DN-p63/p73 [Table 3
and Figure 3] and the miRNA processing components [Figure 5]
(production will need this reference to link the reader to the figure)
[84]. Further, the data discussed in this article suggest that TA-
p73/p63 is no longer a phantom of a tumor suppressor, but it is
indeed function as a tumor suppressor.
Considering that a number of miRNAs function as tumor
suppressor genes [32,40,45,73,76], it is of great importance to
understand how the guardians of the genome, p53, p63, and
p73 regulate the miRNA processing machinery. Given that a
number of components–DGCR8, XPO5, TNRC6B, Ago1/2,
T A R B P 2 ,H S P C A ,S E R B P 1 A ,a n dD i c e r – o ft h em i R N A -
processing complex are down regulated in cancer [1], it is
unsurprising that they could be regulatory targets of the
guardians of the genome. In conclusion, the data discussed in
this article not only provide insights into how p53, p63, and p73
function as regulators of the miRNA processing machinery, but
also how they inhibit tumorigenesis, EMT, metastasis and CSC
proliferation.
Table 4. p53-microRNAs that target multiple components of
the miRNA processing machinery.
Components of
miRNA- processing
complex
p53-miRs that
commonly target
components
of the miRNA
processing complex
Target scan/
Mami(in
decimals)/
miTG(in italics)
score (human)
TARBP2
Dicer
Lin-28
Lin-28B
Ago 3
Ago 4
mLIN41
let-7 66–72
31.95
93
98
44–49
60–65
97
Dicer
RCK
Exportin 5
Ago1
TNRC6B
Lin-28b
miR-124 14.2
96
12.72
14.18
32.36
15.63
KHSRP
ILF3
RAN
Lin-28
Lin-28B
mLIN-41
miR-181 -
81
0.25860
92
75
95
doi:10.1371/journal.pone.0010615.t004
Figure 5. This working model shows how p53, p63, p73, and their target miRNAs regulate the microRNA-processing components. It
was drawn using biotapestry software [87].
doi:10.1371/journal.pone.0010615.g005
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Identification of p53/p63-REs present in the promoters of
components of the miRNA complex
miRNA processing components’ promoter sequences were
downloaded from http://genome.ucsc.edu/. -5000bps upstream
to transcription starting sites was analyzed for p53/p63REs using
TRANSFAC. p53/p63-REs’ [RRRCWWGYYY] core sequence
is underlined.
Curated p53-dependent or p53-inducing miRNA data
A list of p53-dependent or p53-inducing miRNAs (data not
shown) was prepared from the published microarray data [56, 69,
70, Boominathan, unpublished].
Identification of miRNAs using Target scan, Diana, and
Mami bioinformatics tools
miRNAs that target miRNA processing components were
analyzed using Target scan [http://www.targetscan.org/], Diana
[http://diana.cslab.ece.ntua.gr/microT/] and Mami [http://
mami.med.harvard.edu/] softwares.
a. Target scan: This site is used for the prediction of miRNA
target genes. Importantly, it indicates whether the identified
miRNA is conserved across several genomes. It also indicates the
number of times the seed sequence of an miR matches with the
39UTR sequence of mRNAs. Accuracy of the predicated target
can be determined from the context percentile score.
b. Diana: This site also provides a list of predicted miRNAs for
the chosen mRNA. This program appears to provide a highly
sensitive score compared to other programs.
c. Mami: This site can be used to find out whether the
identified targeting miRNA is predicted by more than one
program. This site provides a comparison of five different
programs, such as, Targetscan, miRanda, microT, miRtarget,
and picTar. Mami score is presented in decimals (miTG).
Numerous miRNAs appear to target the components of the
miRNA processing complex. However, only p53-dependent miR-
NAs wereselected for furtheranalysis(refer to Table2 [S2] & 4 [S3]).
Comparative/computational miRNA analysis
A p53-miR is considered conserved if it targets more than one
component of the miRNA- processing complex. Keeping this as a
criteria for selection, a list of p53-miRs that targets more than one
component of the miRNA processing complex was prepared (refer
to Table 4/S3).
Supporting Information
Table S1 The miRNA biosynthesis pathway component’s
promoters contain p53/p63-REs.
Found at: doi:10.1371/journal.pone.0010615.s001 (0.05 MB
DOC)
Table S2 p53/p63/p63-miRs that target components of the
miRNA biosynthesis pathway.
Found at: doi:10.1371/journal.pone.0010615.s002 (0.05 MB
DOC)
Table S3 p53-miRs that target more than one component of the
miRNA processing machinery.
Found at: doi:10.1371/journal.pone.0010615.s003 (0.05 MB
DOC)
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